FibroBiologics
FBLG • NASDAQ
FibroBiologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter O'Heeron, with a market cap of $6.3M.
Market Cap$6.3M
Employees8.0
CEOPeter O'Heeron
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
FibroBiologics FAQ
Common questions about FibroBiologics
FibroBiologics is scheduled to report earnings for Q1 2026 on May 13, 2026.
FibroBiologics has approximately 8 employees.